IP Library › Granted Patent US 12,523,643
Granted Patent B2
US 12,523,643 · App. 17/966,860 · Granted Jan 13, 2026

System and method for assessing biological tissue

Inventors: Fartash Vasefi (Sherman Oaks, CA); Kenneth Edward Barton (Palm City, FL); Nicholas Bennett MacKinnon (Salt Spring Island, CA); Abdolrahim Zandi (Laguna Niguel, CA); Kouhyar Tavakolian (Grand Forks, ND)
Assignee: SafetySpect Inc.
G01N33/12G01N21/49G01N21/55G01N21/645G01N21/65G01N2201/127G06N20/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,523,643
App. No.
17/966,860
Granted
Jan 13, 2026
Kind
B2
Abstract

A system for assessing biological tissue is disclosed. The system contains an illumination hardware arrangement comprising transmission and sensing hardware, the illumination hardware arrangement configured to inspect a biological tissue using at least two modes from a group containing: a three dimensional stereo imaging mode; a fluorescence imaging mode; a reflectance imaging mode; and a thermal imaging mode; and processing hardware configured to operate the illumination hardware arrangement according to a protocol comprising inspection settings of the at least two modes, wherein the processing hardware receives scan results for the at least two modes from the illumination hardware arrangement and identifies attributes of the biological tissue by constructing a three dimensional dataset from the scan results for the at least two modes and analyzing the three dimensional dataset.

Claims (24)

1 . A system for assessing biological tissue, the system comprising:

an illumination hardware arrangement comprising transmission and sensing hardware, the illumination hardware arrangement configured to inspect a biological tissue using at least two modes from a group comprising:

a three dimensional stereo imaging mode;

a fluorescence imaging mode;

a hyperspectral imaging mode; and

a thermal imaging mode; and

the system further comprising one or more 3D stereoscopic imaging cameras, wherein each stereoscopic imaging camera includes two sensors spaced a known distance apart such that each stereoscopic imaging camera takes two images from the two sensors and compares them to provide morphological information; and

the system further comprising one or more thermal imaging cameras to provide at least one of IR images and thermal images; and

processing hardware configured to operate the illumination hardware arrangement according to a protocol comprising inspection settings of the at least two modes, wherein the processing hardware receives scan results for the at least two modes from the illumination hardware arrangement and identifies attributes of the biological tissue by constructing a three dimensional dataset from the scan results for the at least two modes and analyzing the three dimensional dataset.

2 . The biological tissue inspection apparatus of claim 1 , wherein the biological tissue comprises a wound on a patient's skin.

3 . The biological tissue inspection apparatus of claim 1 , wherein the processing hardware comprises a processor, at least one trained artificial intelligence module, and at least one classifier.

4 . The biological tissue inspection apparatus of claim 1 , wherein the biological tissue comprises a burn on a patient's skin.

5 . The biological tissue inspection apparatus of claim 1 , wherein the protocol is determined in part based on an identification of particular attributes expected to be associated with the biological tissue when examined using the at least two modes.

6 . The biological tissue inspection apparatus of claim 1 , wherein the system determines presence of infection associated with the biological tissue.

7 . The biological tissue inspection apparatus of claim 1 , wherein the identified attributes are infection associated with the biological tissue.

8 . The biological tissue inspection apparatus of claim 1 , wherein the identified attributes are metabolic biomarkers associated with the biological tissue.

9 . The biological tissue inspection apparatus of claim 1 , wherein the illumination hardware comprises one or more pulsating light sources to reduce ambient light sources for the at least two modes.

10 . The biological tissue inspection apparatus of claim 1 , wherein the identified attributes are collagen associated with the biological tissue.

11 . The biological tissue inspection apparatus of claim 1 , wherein the identified attributes are oxygenation associated with the biological tissue.

12 . The biological tissue inspection apparatus of claim 1 , wherein the system identifies treatment based on the three dimensional dataset.

13 . The biological tissue inspection apparatus of claim 1 , wherein the system identifies billing code based on the three dimensional dataset.

14 . The biological tissue inspection apparatus of claim 1 , wherein the system identifies treatment based on the three dimensional dataset.

15 . The biological tissue inspection apparatus of claim 2 , wherein the system classifies the wound based on the three dimensional dataset.

16 . The biological tissue inspection apparatus of claim 4 , wherein the system classifies the burn based on the three dimensional dataset.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2022
From: VASEFI, FARTASH; ZANDI, ABDOLRAHIM; BARTON, KENNETH EDWARD; TAVAKOLIAN, KOUHYAR; MACKINNON, NICHOLAS BENNET
To: SAFETYSPECT INC
Reel/Frame 061435/0728 →
Continuity (4)
Continuation In Part 17681568 · Feb 25, 2022
Continuation 16358531 · Mar 19, 2019
Provisional Application 63256571 · Oct 16, 2021
Related Publication 20240027417A1 · Jan 25, 2024
References Cited (4)
US 11885788B2 · Farkas · 2024 [cited by examiner]
US 20100330578A1 · Duhr · 2010 [cited by examiner]
US 20210363579A1 · Daugharthy · 2021 [cited by examiner]
WO WO2018165577A1 · 2018 [cited by examiner]